DHR Add to watchlist
$207.44 1.93 (-0.92%)
After Hours: $207.44 +0.00 (+0.00%)
Last updated: Aug 11, 2026 21:14
52-Week Range
$207.44
$160.93 $207.44 $242.80

Fundamentals Overview

Danaher Corporation is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 36.7 PEG 2.12 P/B 2.78 P/S 5.81

Intrinsic value (DCF)

+4.6% upside vs price

Profitability

Net margin 15.9%

Risk (Beta)

0.8 — in line vol

Earnings & growth

EPS $5.66 Rev +5.3% Profit -15.5% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 58% confidence Risk: Moderate Volatility — Beta 0.8. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · 3M vs S&P 500: +16.7%

Pressures (Sell):

Sentiment weakening (2 downgrades)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$145.83B
P/E (TTM)
36.66
EPS (TTM)
$5.66
Dividend Yield
0.69%
52-Week Range
$160.93 - $242.80
Volume vs Avg
N/A
Beta
0.8

About

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific resea...
Sector: Healthcare
Headquarters: US
Employees: 59,000
IPO Date: Dec 1978
Beta: 0.8 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 13, Equal Weight: 4, Neutral: 3, Outperform: 6, Overweight: 4.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $217.05; current price is $207.44. That’s a +4.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 36.66
DCF value (model) $217.05 (4.6% upside)
PEG (TTM) 2.12
P/B (TTM) 2.78
P/S (TTM) 5.81
P/FCF (TTM) 26.68
Liquidity & enterprise
Current Ratio (TTM) 1.65
Quick Ratio (TTM) 1.25
Cash Ratio (TTM) 0.54
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 15.95%
Gross margin (TTM) 58.51%
Operating margin (TTM) 20.42%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for DHR.

Analyst Sentiment at a Glance

B Sentiment Weakening
Buy 13Equal Weight 4Neutral 3Outperform 6Overweight 4
0 upgrades, 2 downgrades
Price Target Consensus
Current $207.44
Median $225.00
Consensus $221.58
Low consensus $195.00
High consensus $249.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Wells Fargo maintain Equal Weight Equal Weight 2026-07-22
Stifel maintain Buy Buy 2026-07-22
RBC Capital maintain Outperform Outperform 2026-07-22
TD Cowen maintain Buy Buy 2026-07-22
Guggenheim maintain Buy Buy 2026-07-22
Evercore ISI Group maintain Outperform Outperform 2026-07-06
Piper Sandler maintain Neutral Neutral 2026-06-11
HSBC maintain Buy Buy 2026-06-03
Citigroup downgrade Buy Neutral 2026-05-27
Morgan Stanley maintain Overweight Overweight 2026-04-23
Baird maintain Outperform Outperform 2026-04-22
Wells Fargo maintain Equal Weight Equal Weight 2026-04-22
UBS maintain Buy Buy 2026-04-22
Guggenheim maintain Buy Buy 2026-04-22
Baird maintain Outperform Outperform 2026-04-17
Barclays maintain Overweight Overweight 2026-04-14
Goldman Sachs maintain Buy Buy 2026-04-13
Evercore ISI Group maintain Outperform Outperform 2026-04-06
JP Morgan maintain Overweight Overweight 2026-01-29
Jefferies maintain Buy Buy 2026-01-29
TD Cowen maintain Buy Buy 2026-01-07
Guggenheim maintain Buy Buy 2026-01-05
Wells Fargo maintain Equal Weight Equal Weight 2025-12-15
Wells Fargo maintain Equal Weight Equal Weight 2025-10-23
TD Cowen maintain Buy Buy 2025-10-22
Barclays maintain Overweight Overweight 2025-10-22
Rothschild & Co downgrade Buy Neutral 2025-10-08
Evercore ISI Group maintain Outperform Outperform 2025-10-07
B of A Securities maintain Buy Buy 2025-09-22
UBS maintain Buy Buy 2025-07-23